The FDA is considering removing marijuana from its list of the most dangerous and harmful drugs. This could signal a radical shift in the way our government regulates and enforces weed.
It would be huge for marijuana legalization on all levels. Schedule 2 status will mean that weed for research will become more abundant, allowing scientists to finally crack the mysterious therapeutic value of cannabis, giving us evidence of its efficacy through controlled clinical trials rather than anecdotal data from self-prescribers. Another benefit is that state lawmakers will have one less reason to stand against medical marijuana in their states — a change in the federal government’s stance is a signal to the rest of the country.